-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data
Eric D Jacobsen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation